News Nov 23, 2022 Geneva biopharma ObsEva sells its Ebopiprant license for up to USD 113 million Women's and reproductive health specialist ObsEva has announced the sale of its license for ebopiprant to California-based biotech company Xoma f...
News Nov 23, 2022 Chip set to replace animal testing for embryo research Researchers from Empa, the Swiss Federal Institute of Technology in Zurich and the St.Gallen Cantonal Hospital have joined forces to develop an a...
News Nov 07, 2022 Idiap and InflamAlps partner up to accelerate antibiotic research using artificial intelligence The result of a partnership between Valais-based pharma company InflamAlps and the Idiap institute, the ABRoad project aims to accelerate the sel...
News Oct 26, 2022 Chinese vaccine manufacturer CanSino Biologics sets up shop in Geneva to launch its inhaled Covid vaccine This first inhaled Covid vaccine against was approved by Chinese authorities a month ago. This technology has the potential to protect against ot...
News Oct 26, 2022 Sumitovant acquires all shares in Myovant Sumitovant is in the process of making Myovant a wholly owned subsidiary by acquiring a 100 percent shareholding in the company for 27 dollars pe...
News Oct 24, 2022 VectivBio raises 125 million US dollars in stock sale VectivBio has announced the closing of the subscription offer for 16,700,000 ordinary shares. The biotechnology firm has generated gross proceeds...
News Oct 17, 2022 1STMC: Switzerland’s first translational medicine conference Organized by sitem-insel, the 1st Swiss Translational Medicine Conference will take place in Bern on 27 October 2022.
News Oct 17, 2022 Escientia Switzerland becomes Primopus The Indian company Deccan Fine Chemicals is acquiring Escientia Switzerland and renaming it as Primopus AG. The Swiss subsidiary of America’s Esc...
News Oct 14, 2022 PSI and Apollo Health Ventures research biology of aging The Paul Scherrer Institute (PSI) and Apollo Health Ventures have established Focal Biosciences. Under the management of cellular reprogramming e...
News Oct 06, 2022 Biopôle expands further with the construction of three new buildings Biopôle has announced that Edmond de Rothschild Real Estate SICAV will be investing in the construction of three new buildings on the campus in E...
News Sep 26, 2022 Western Switzerland start-ups celebrated at the TOP 100 Swiss Startups Award Just behind Zurich, start-ups from the cantons of Vaud, Bern Geneva and Valais led the twelfth edition of the TOP 100 Swiss Startups Award.
News Aug 15, 2022 Versant Ventures establishes Vector BioPharma AG Vector Biopharma is the latest company to be founded by Ridgeline, a discovery engine from Basel-based venture capitalist Versant Ventures. Vecto...
News Aug 15, 2022 BioFi AG newly settles in Basel BioFi has set up its headquarters in Basel. The company has emerged from Crowley Davis Research, which was established in the US state of Idaho i...
News Jul 20, 2022 Forty51 closes first fund totaling 43 million US dollars A new Basel-based venture fund, Forty51 Ventures I, has raised a total of 43 million US dollars following a first fund closing. Forty51 invests i...
News Jul 06, 2022 Qarad, part of the QbD Group, expands to Switzerland Belgian-based IVD specialist Qarad is your gateway to Europe for In Vitro Diagnostics and Medical Devices. The company has recently opened a new ...
News Jul 05, 2022 CHF 178 million to further develop life sciences in the canton of Vaud To consolidate the development of life sciences in the canton of Vaud, the State Council has announced an investment of CHF 178.71 million in the...
News Jun 21, 2022 KBI Biopharma and Selexis open a new biologics manufacturing facility in Geneva KBI Biopharma and Selexis, both JSR Life Sciences companies, announced that an expanded, fully-integrated mammalian contract development and manu...
News May 20, 2022 BeiGene opens European headquarters in Basel BeiGene has opened its new European headquarters in Basel. The global biotech company specializing in innovative cancer treatments intends to bui...